Original article
Impact of mammary grafts on coronary bypass operative mortality and morbidity,☆☆

https://doi.org/10.1016/0003-4975(94)90546-0Get rights and content

Abstract

The internal mammary artery is frequently used as a coronary artery bypass graft conduit because of superior long-term patency. The purpose of this study was to determine if there was also an advantage to the internal mammary artery in terms of operative mortality and morbidity. The Department of Veterans Affairs Cardiac Surgery Database was reviewed for two separate time periods, April 1987 through March 1989 and October 1990 through September 1991. During these periods, 14,172 patients underwent coronary artery bypass grafting. Univariate and multivariate logistic regression analyses were used to determine preopetative variables predictive of operative mortality and morbidity, with the independent variable of use of the internal mammary artery added to previously determined indicators. The total group was analyzed in risk quartiles according to expected mortality. Univariate analysis revealed an operative mortality of 6.8% in the early period and 6.5% in the latter period for the saphenous vein groups compared with 3.7% and 3.2%, respectively, for the internal mammary artery groups (p = 0.000). Multivariate analysis revealed an odds ratio of operative death with use of the internal mammary artery graft versus use of vein grafts of 0.78 during the first period and 0.72 during the second period, reductions of 22% and 28%, respectively. There were 29% and 37% reductions in the odds of operative mortality in the highest-risk quartile group of patients using the internal mammary artery graft. The odds ratio of developing mediastinitis with one internal mammary artery graft was 1.84 (p < 0.01) in the first time period and 1.11 in the second time period (p = not significant). However, with multiple mammary bypass grafts, the odds ratios were 3.70 (p < 0.01) and 2.96 (p < 0.01) in the respective time periods. On the basis of this study, it is concluded that internal mammary artery grafts in addition to providing superior long-term patency also decreased operative mortality after adjustment for patient risk factors. Use of the mammary artery does not consistently increase operative complications with the exception of mediastinitis when both internal mammary arteries are employed.

Cited by (79)

  • Technique of Y and T grafts

    2020, Technical Aspects of Modern Coronary Artery Bypass Surgery
  • Bilateral internal thoracic artery grafting in India—Time to raise the bar

    2017, Indian Heart Journal
    Citation Excerpt :

    The objective of coronary artery bypass graft (CABG) surgery is to ameliorate the symptoms of patients with coronary artery disease and of long– term survival benefit.1 The use of left internal thoracic artery (LITA) to bypass stenosed left anterior descending (LAD) coronary artery as a surgical strategy in patients undergoing coronary artery bypass grafting has demonstrated improved survival which may be due to the higher rates of long-term patency of LITA grafts.2–4 The evidence of improved survival from several observational studies is so convincing that over 95% of patients undergoing CABG in the Unites States and 90% of patients in United Kingdom receive at least one ITA graft.5,6

  • Mediastinitis

    2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  • Risk stratification and prognostic effects of internal thoracic artery grafting during acute myocardial infarction

    2013, Journal of Thoracic and Cardiovascular Surgery
    Citation Excerpt :

    The positive benefits of ITA grafting on long-term survival, freedom from cardiac events, reoperation, and graft patency are well documented.19,20 Lower operative mortality also has been reported in the general population undergoing CABG.21-23 However, outcomes with ITA grafting in the early post-MI state have not been studied, and in the present analysis, ITA grafting in patients with MI in less than 24 hours was associated with a halving of operative mortality.

View all citing articles on Scopus

Presented at the Twenty-ninth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 25–27, 1993.

☆☆

Supported by the Department of Veterans Affair Health Services Research and Development Service and the Office of Quality Management, Department of Veterans Affairs Central Office.

View full text